These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 27215077)

  • 1. Elevated Serum Levels of Sclerostin are Associated with High Disease Activity and Functional Impairment in Patients with Axial Spondyloarthritis.
    Muntean L; Lungu A; Gheorghe SR; Valeanu M; Craciun AM; Felea I; Petcu A; Filipescu I; Simon SP; Rednic S
    Clin Lab; 2016; 62(4):589-97. PubMed ID: 27215077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study.
    Kilic E; Kilic G; Akgul O; Ozgocmen S
    Rheumatol Int; 2015 Jun; 35(6):981-9. PubMed ID: 25366469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical improvement and reduction in serum calprotectin levels after an intensive exercise programme for patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis.
    Levitova A; Hulejova H; Spiritovic M; Pavelka K; Senolt L; Husakova M
    Arthritis Res Ther; 2016 Nov; 18(1):275. PubMed ID: 27887637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there any gender-specific difference in the cut-off values of ankylosing spondylitis disease activity score in patients with axial spondyloarthritis?
    Kilic G; Kilic E; Ozgocmen S
    Int J Rheum Dis; 2017 Sep; 20(9):1201-1211. PubMed ID: 27309497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity and reliability of the Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with axial spondyloarthritis (axSpA) in Singapore.
    Kwan YH; Tan JJ; Phang JK; Fong W; Lim KK; Koh HL; Lui NL; Tan CS; Østbye T; Thumboo J; Leung YY
    Int J Rheum Dis; 2019 Dec; 22(12):2206-2212. PubMed ID: 31721427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal Association Between Trabecular Bone Loss and Disease Activity in Axial Spondyloarthritis: A 4-year Prospective Study.
    Kang KY; Ju JH; Park SH; Hong YS
    J Rheumatol; 2020 Sep; 47(9):1330-1337. PubMed ID: 31732556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relevance of structural damage in the sacroiliac joints for the functional status and spinal mobility in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort.
    Protopopov M; Sieper J; Haibel H; Listing J; Rudwaleit M; Poddubnyy D
    Arthritis Res Ther; 2017 Oct; 19(1):240. PubMed ID: 29065931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of serum fibroblast growth factor-23 in patients with axial spondyloarthritis and its association with sclerostin, inflammation, and spinal damage.
    Gercik O; Solmaz D; Coban E; Iptec BO; Avcioglu G; Bayindir O; Kabadayi G; Topal FE; Kozaci D; Akar S
    Rheumatol Int; 2019 May; 39(5):835-840. PubMed ID: 30968207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive correlation between inflammation on sacroiliac joint MRI and serum C-terminal telopeptide of type-I collagen in ankylosing spondylitis but not in non-radiographic axial spondyloarthritis.
    Kang KY; Jung JY; Hong YS; Ju JH; Park SH
    Clin Exp Rheumatol; 2017; 35(3):415-422. PubMed ID: 27974096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors.
    Pedersen SJ; Sørensen IJ; Garnero P; Johansen JS; Madsen OR; Tvede N; Hansen MS; Thamsborg G; Andersen LS; Majgaard O; Loft AG; Erlendsson J; Asmussen K; Jurik AG; Møller J; Hasselquist M; Mikkelsen D; Skjødt T; Lambert R; Hansen A; Østergaard M
    Ann Rheum Dis; 2011 Aug; 70(8):1375-81. PubMed ID: 21551511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of serum interleukin-17 and interleukin-23 levels with disease activity in Chinese patients with ankylosing spondylitis.
    Chen WS; Chang YS; Lin KC; Lai CC; Wang SH; Hsiao KH; Lee HT; Chen MH; Tsai CY; Chou CT
    J Chin Med Assoc; 2012 Jul; 75(7):303-8. PubMed ID: 22824043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum metalloproteinase-3 levels in assessing efficacy of Etanercept in patients with ankylosing spondylitis].
    Wang QH; Zhang SZ; Xue J; Wu HX
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 39(4):409-14. PubMed ID: 20731042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation between sclerostin level and radiographic changes in patients with ankylosing spondylitis].
    Xie J; Yu X
    Zhonghua Yi Xue Za Zhi; 2015 May; 95(17):1300-4. PubMed ID: 26081658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between psychiatric status, self-reported outcome measures, and clinical parameters in axial spondyloarthritis.
    Kilic G; Kilic E; Ozgocmen S
    Medicine (Baltimore); 2014 Dec; 93(29):e337. PubMed ID: 25546683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained low functional impairment in axial spondyloarthritis (axSpA): which are the primary outcomes that should be targeted to achieve this?
    Maksymowych WP; Inman RD; Bessette L; Rahman P; Rampakakis E; Asin-Milan O; Rachich M; Marrache AM; Lehman AJ
    Arthritis Res Ther; 2023 Apr; 25(1):70. PubMed ID: 37118833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Discriminative Values of the Bath Ankylosing Spondylitis Disease Activity Index, Ankylosing Spondylitis Disease Activity Score, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Spondyloarthritis-Related Axial Arthritis.
    Tsang HHL; Chung HY
    J Clin Rheumatol; 2017 Aug; 23(5):267-272. PubMed ID: 28661926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sera of patients with axial spondyloarthritis (axSpA) enhance osteoclastogenic potential of monocytes isolated from healthy individuals.
    Korkosz M; Czepiel M; Guła Z; Stec M; Węglarczyk K; Rutkowska-Zapała M; Gruca A; Lenart M; Baran J; Gąsowski J; Błyszczuk P; Siedlar M
    BMC Musculoskelet Disord; 2018 Dec; 19(1):434. PubMed ID: 30522483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolites of C-reactive protein and vimentin are associated with disease activity of axial spondyloarthritis.
    Siebuhr AS; Hušaková M; Forejtová S; Zegzulková K; Tomčik M; Urbanová M; Grobelná K; Gatterová J; Bay-Jensen AC; Pavelka K
    Clin Exp Rheumatol; 2019; 37(3):358-366. PubMed ID: 30767876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of bone morphogenic protein 2 and interleukin-17A in patients with axial spondyloarthritis and their potential role in the new bone formation: a cross-sectional study.
    Perrotta FM; Scriffignano S; Lubrano E
    Clin Exp Rheumatol; 2019; 37(6):1044-1047. PubMed ID: 31376251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis?
    Kiltz U; Baraliakos X; Karakostas P; Igelmann M; Kalthoff L; Klink C; Krause D; Schmitz-Bortz E; Flörecke M; Bollow M; Braun J
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1415-22. PubMed ID: 22505331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.